Abstract:BACKGROUND:Emodin, a traditional Chinese medicine, has a therapeutic effect on severe acute pancreatitis (SAP), whereas the underlying mechanism is still unclear. Studies showed that the intestinal mucosa impairment, and subsequent release of endotoxin and proinflammatory cytokines such as IL-1β, which further leads to the dysfunction of multiple organs, is the potentially lethal mechanism of SAP. Caspase-1, an IL-1β-converting enzyme, plays an important role in this cytokine cascade process. Investigation of the effect of emodin on regulating the caspase-1 expression and the release proinflammatory cytokines will help to reveal mechanism of emodin in treating SAP.METHODS:Eighty Sprague-Dawley rats were randomly divided into four groups (n=20 each group): SAP, sham-operated (SO), emodin-treated (EM) and caspase-1 inhibitor-treated (ICE-I) groups. SAP was induced by retrograde infusion of 3.5% sodium taurocholate into the pancreatic duct. Emodin and caspase-1 inhibitor were given 30 minutes before and 12 hours after SAP induction. Serum levels of IL-1β, IL-18 and endotoxin, histopathological alteration of pancreas tissues, intestinal mucosa, and the intestinal caspase-1 mRNA and protein expressions were assessed 24 hours after SAP induction.RESULTS:Rats in the SAP group had higher serum levels of IL-1β and IL-18 (P<0.05), pancreatic and gut pathological scores (P<0.05), and caspase-1 mRNA and protein expressions (P<0.05) compared with the SO group. Compared with the SAP group, rats in the EM and ICE-I groups had lower IL-1β and IL-18 levels (P<0.05), lower pancreatic and gut pathological scores (P<0.05), and decreased expression of intestine caspase-1 mRNA (P<0.05). Ultrastructural analysis by transmission electron microscopy found that rats in the SAP group had vaguer epithelial junctions, more disappeared intercellular joints, and more damaged intracellular organelles compared with those in the SO group or the EM and ICE-I groups.CONCLUSIONS:Emodin alleviated pancreatic and intestinal mucosa injury in experimental SAP. Its mechanism may partly be mediated by the inhibition of caspase-1 and its downstream inflammatory cytokines, including IL-1β and IL-18. Our animal data may be applicable in clinical practice.

The Antagonist Of The Jak-1/Stat-1 Signaling Pathway Improves The Severity Of Cerulein-Stimulated Pancreatic Injury Via Inhibition Of Nf-Kappa B Activity

Effect of JAK2/STAT3 Signaling Pathway on Liver Injury Associated with Severe Acute Pancreatitis in Rats.

Expression of Janus Kinase 1/signal Transducer and Activator of Transcription 1 Signaling Pathway in Cerulean Stimulated Pancreatic Acinar Cells

Emodin Alleviates Intestinal Mucosal Injury in Rats with Severe Acute Pancreatitis Via the Caspase-1 Inhibition.

Regulatory Roles Of The Pi3k/Akt Signaling Pathway In Rats With Severe Acute Pancreatitis

The Significance of Protein Kinase C-nuclear Factor-Κb Pathway in Sever Acute Pancreatitis-Associated Hepatic Injury in Rats

Effects of Gut Barrier Dysfunction and NF-kappaB Activation on Aggravating Mechanism of Severe Acute Pancreatitis.

Upregulation of PIAS1 Protects Against Sodium Taurocholate-Induced Severe Acute Pancreatitis Associated with Acute Lung Injury

Study of the Protective Effects of Dexamethasone on Ileum Mucosa Injury in Rats with Severe Acute Pancreatitis.

Role of Nuclear Factor-Kappab, Reactive Oxygen Species and Cellular Signaling in the Early Phase of Acute Pancreatitis.

The Effect of Inhibiting Janus Kinase/signal Transducer and Activator of Transcription Pathway on NF-κB Expression in Pancreatic Acinar Cell Line AR42J

Effect of STAT-1 on Expression of Intercellular Adhesion Molecule-1 in Rats with Acute Pancreatitis

Sphingosine 1-phosphate receptor 2 mediated early stages of pancreatic and systemic inflammatory responses via NF-kappa B activation in acute pancreatitis

Change of activity of STAT-1 in pancreatic tissue in rats with severe acute pancreatitis

Activated Protein C Improves the Severity of Severe Acute Pancreatitis via Up-Regulating the Expressions of Endothelial Cell Protein C Receptor and Thrombomodulin

Inhibition Of Glycogen Synthase Kinase-3 Beta Attenuates Acute Kidney Injury In Sodium Taurocholate-Induced Severe Acute Pancreatitis In Rats

Adenosine Kinase Inhibition Prevents Severe Acute Pancreatitis via Suppressing Inflammation and Acinar Cell Necroptosis

Fractalkine Upregulates Inflammation through CX3CR1 and the Jak–Stat Pathway in Severe Acute Pancreatitis Rat Model

Deletion Of Xiap Reduces The Severity Of Acute Pancreatitis Via Regulation Of Cell Death And Nuclear Factor-Kappa B Activity

PD-L1 blockade in mitigating severe acute pancreatitis induced pancreatic damage through modulation of immune cell apoptosis

The Role of Nuclear Factor-kappa B in the Pathogenesis of Severe Acute Pancreatitis-Associted Lung Injury